Skip to main content
Professional Technical IVT

factor IX deficiency

X-linked bleeding disorder caused by deficient or dysfunctional coagulation factor IX, also known as hemophilia B.

Full Definition

Factor IX deficiency, also known as hemophilia B or Christmas disease, is an X-linked recessive bleeding disorder caused by mutations in the F9 gene leading to deficient or dysfunctional factor IX protein. The condition affects approximately 1 in 30,000 male births and is clinically indistinguishable from hemophilia A, presenting with bleeding into joints, muscles, and other organs. Severity correlates with residual factor IX activity levels: severe (<1%), moderate (1-5%), or mild (5-40%). Treatment involves factor IX replacement therapy, with newer options including extended half-life products and gene therapy.

Usage

Usage note: Use Roman numeral IX. Specify severity level when known. Hemophilia B is acceptable alternative term.

In Context

  • "Genetic testing confirmed severe factor IX deficiency with a nonsense mutation in exon 7." — Genetics consultation
  • "The patient's factor IX level was 2%, consistent with moderate hemophilia B." — Coagulation laboratory report

Also known as

hemophilia B Christmas disease FIX deficiency

Don't confuse with

hemophilia A factor VIII deficiency von Willebrand disease

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON